Muscarinic receptor upregulation in patients with myocardial infarction: A new paradigm

Circulation: Cardiovascular Imaging

Volumn 2, Issue 5, 2009, Pages 365-372

  Chevalier, Philippe ^b,c   Mazzadi, Alejandro N ^a   Pineau, Julien ^b,c   Costes, Nicolas ^a   Le Bars, Didier ^a,c   Bonnefoi, Franck ^a   Croisille, Pierre ^b,c   Porcher, Raphaël ^d  

^a CERMEP IMAGERIE DU VIVANT   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

MRI; Myocardial infarction; Receptors; Tomography

Indexed keywords

GADOLINIUM PENTETATE; METHYLQUINUCLIDINYLBENZILATE C 11; MUSCARINIC RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARBON; CLIDINIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; LIGAND; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDINYL BENZILATE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART INFARCTION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; WHOLE BODY PET; AGED; CASE CONTROL STUDY; CHEMISTRY; HEART MUSCLE; HEART VENTRICLE; INNERVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; UPREGULATION; VAGUS NERVE;

ADULT; AGED; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; HEART VENTRICLES; HUMANS; LIGANDS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; MYOCARDIAL INFARCTION; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; QUINUCLIDINYL BENZILATE; RADIOPHARMACEUTICALS; RECEPTORS, MUSCARINIC; UP-REGULATION; VAGUS NERVE;

EID: 70350502333     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.108.822106     Document Type: Article

References (35)

1. Garnier D. [Acetylcholine and the myocardium: electrophysiological aspects]. J Physiol (Paris). 1987;82:145-159.
2. Koumi S, Sato R, Nagasawa K, Hayakawa H. Activation of inwardly rectifying potassium channels by muscarinic receptor-linked G protein in isolated human ventricular myocytes. J Membr Biol. 1997;157:71-81.
3. Bonnemeier H, Notges JK, Majunke B, Strassburg A, Ortak J, Kothe H, Weitz G, Schunkert H. Ventricular repolarization dynamics during different sleep stages in the subacute phase of myocardial infarction. Pacing Clin Electrophysiol. 2007;30(Suppl 1):S192-S197.
4. Zipes DP, Rubart M. Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm. 2006;3:108-113.
5. Sasano T, Abraham MR, Chang KC, Ashikaga H, Mills KJ, Holt DP, Hilton J, Nekolla SG, Dong J, Lardo AC, Halperin H, Dannals RF, Marban E, Bengel FM. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol. 2008;51:2266-2275.
6. Zheng C, Li M, Inagaki M, Kawada T, Sunagawa K, Sugimachi M. Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf Proc IEEE Eng Med Biol Soc. 2005;7:7072-7075. (Pubitemid 46230607)
7. Inagaki M, Kawada T, Lie M, Zheng C, Sunagawa K, Sugimachi M. Intravascular parasympathetic cardiac nerve stimulation prevents ventricular arrhythmias during acute myocardial ischemia. Conf Proc IEEE Eng Med Biol Soc. 2005;7:7076-7079.
8. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998; 351:478-484.
9. Frenneaux MP. Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart. 2004;90:1248-1255.
10. Delforge J, Janier M, Syrota A, Crouzel C, Vallois JM, Cayla J, Lancon JP, Mazoyer BM. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation. 1990;82:1494-1504.
11. Delforge J, Le Guludec D, Syrota A, Bendriem B, Crouzel C, Slama M, Merlet P. Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med. 1993;34:981-991.
12. Le Guludec D, Delforge J, Syrota A, Desruennes M, Valette H, Gandjbakhch I, Merlet P. In vivo quantification of myocardial muscarinic receptors in heart transplant patients. Circulation. 1994;90:172-178.
13. Le Guludec D, Cohen-Solal A, Delforge J, Delahaye N, Syrota A, Merlet P. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: an in vivo PET study. Circulation. 1997;96:3416-3422.
14. Delahaye N, Le Guludec D, Dinanian S, Delforge J, Slama MS, Sarda L, Dolle F, Mzabi H, Samuel D, Adams D, Syrota A, Merlet P. Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation. 2001; 104:2911-2916.
15. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/Am College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21: 1502-1513.
16. Frouin V, Comtat C, Reilhac A, Gregoire MC. Correction of partialvolume effect for PET striatal imaging: fast implementation and study of robustness. J Nucl Med. 2002;43:1715-1726.
17. Ibrahim T, Nekolla SG, Hornke M, Bulow HP, Dirschinger J, Schomig A, Schwaiger M. Quantitative measurement of infarct size by contrastenhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol. 2005;45:544-552.
18. Mazzadi AN, Janier MF, Brossier B, Andre-Fouet X, McFadden E, Revel D, Croisille P. Dobutamine-tagged MRI for inotropic reserve assessment in severe CAD: relationship with PET findings. Am J Physiol Heart Circ Physiol. 2004;286:H1946-H1953.
19. Mazzadi AN, Andre-Fouet X, Costes N, Croisille P, Revel D, Janier MF. Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning. Am J Physiol Heart Circ Physiol. 2006;291:H2570-H2582.
20. Czernin J, Porenta G, Brunken R, Krivokapich J, Chen K, Bennett R, Hage A, Fung C, Tillisch J, Phelps ME. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation. 1993;88:884-895.
21. Bucciarelli-Ducci C, Ng FS, Symmonds K, Reyes E, Schultz C, Kaddoura S, Prasad SK. Images in cardiovascular medicine: the complex pathophysiology of acute myocardial infarction imaged by cardiovascular magnetic resonance: infarction, edema, microvascular obstruction, and inducible ischemia. Circulation. 2008;118:e89-e92.
22. Vatner DE, Sato N, Galper JB, Vatner SF. Physiological and biochemical evidence for coordinate increases in muscarinic receptors and Gi during pacing-induced heart failure. Circulation. 1996;94:102-107.
23. Wilkinson M, Giles A, Armour JA, Cardinal R. Ventricular, but not atrial, M2-muscarinic receptors increase in the canine pacing-overdrive model of heart failure. Can J Cardiol. 1996;12:71-76.
24. Wise BC, Shoji M, Kuo JF. Decrease or increase in cardiac muscarinic cholinergic receptor number in rats treated with methacholine or atropine. Biochem Biophys Res Commun. 1980;92:1136-1142.
25. Uno Y, Matsumura K, Scheffel U, Wilson AA, Dannals RF, Wagner HN Jr. Effects of atropine treatment on in vitro and in vivo binding of 4-[125I]-dexetimide to central and myocardial muscarinic receptors. Eur J Nucl Med. 1991;18:447-452.
26. Chen LN, Zang WJ, Yu XJ, Liu J, Li DL, Kong SS, Lu J, Xu XL. Compensatory recovery of vagal control of hemodynamics after unilateral vagotomy. Physiol Res. 2008;57:119-132.
27. Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol. 1993; 22:368-375.
28. Abe Y, Sugiura T, Suga Y, Takehana K, Kamihata H, Karakawa M, Inada M, Iwasaka T. Serial assessment of sympathetic reinnervation in a patient with myocardial infarction. J Nucl Med. 1997;38:457-459.
29. Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, Fishbein MC, Sharifi B, Chen PS. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res. 2004;95:76-83.
30. Schwartz PJ. Another role for the sympathetic nervous system in the long QT syndrome. J Cardiovasc Electrophysiol. 2001;12:500-502.
31. Mazzadi AN, Andre-Fouet X, Duisit J, Gebuhrer V, Costes N, Chevalier P, Rodriguez C, Schott JJ, Le Marec H, Guicheney P, Le Bars D, Janier M. Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol. 2003;285:H1286-H1293.
32. Chevalier P, Burri H, Adeleine P, Kirkorian G, Lopez M, Leizorovicz A, Andre-Fouet X, Chapon P, Rubel P, Touboul P. QT dynamicity and sudden death after myocardial infarction: results of a long-term follow-up study. J Cardiovasc Electrophysiol. 2003;14:227-233.
33. Wang Z, Shi H, Wang H. Functional M3 muscarinic acetylcholine receptors in mammalian hearts. Br J Pharmacol. 2004;142:395-408.
34. Perez CC, Tobar ID, Jimenez E, Castaneda D, Rivero MB, Concepcion JL, Chiurillo MA, Bonfante-Cabarcas R. Kinetic and molecular evidences that human cardiac muscle express non-M2 muscarinic receptor subtypes that are able to interact themselves. Pharmacol Res. 2006;54:345-355.
35. Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39:904-911.